SLS · SELLAS Life Sciences Group, Inc.
Market Cap
$2.80B
Shares
201.95M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1390478
CUSIP
81642T209
13F (30d)
121 filings
121 filers
Visit website
Investor relations